Risk of malignancy and the use of disease-modifying therapy in multiple sclerosis: exploring the role of DMT in a multi-center study.
Bayounis M, Bin Mahfooz M, Assiri M, Alghamdi Y, Alturki F, Almutairi M, Alshelawy A, Alosaimi M, Almutawa F, Alammar A, Alyahya Y, Khojah O, Makkawi S, Al Malik Y.
Bayounis M, et al. Among authors: assiri m.
Front Neurol. 2024 Dec 13;15:1492678. doi: 10.3389/fneur.2024.1492678. eCollection 2024.
Front Neurol. 2024.
PMID: 39734635
Free PMC article.